[1]王皎.室性期前收缩性心肌病诊疗进展[J].心血管病学进展,2020,(6):563.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.001]
 WANG Jiao.Diagnosis and Treatment of Premature Ventricular Contraction-induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(6):563.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.001]
点击复制

室性期前收缩性心肌病诊疗进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年6期
页码:
563
栏目:
综述
出版日期:
2020-06-25

文章信息/Info

Title:
Diagnosis and Treatment of Premature Ventricular Contraction-induced Cardiomyopathy
作者:
王皎
(云南省阜外心血管病医院心内科,云南 昆明 650000)
Author(s):
WANG Jiao
( Department of CardiologyFuwai Cardiovascular HospitalKunmingYunnan 650000China)
关键词:
室性期前收缩心肌病射频导管消融
Keywords:
Premature ventricular contractionsCardiomyopathyRadiofrequency catheter ablation
DOI:
10.16806/j.cnki.issn.1004-3934.2020.06.001
摘要:
频发室性期前收缩可导致心脏结构改变,左心室收缩功能降低,最终发展为心肌病,即室性期前收缩性心肌病,目前还需要进一步研究室性期前收缩性心肌病发病机制,以及其发展的危险因素。有效的药物或射频导管消融治疗可预防或逆转室性期前收缩性心肌病,射频导管消融逐渐成为一线治疗方法。
Abstract:
Frequent premature ventricular contractions can lead to changes in cardiac structure and decreased left ventricular dysfunction,and eventually cause cardiomyopathy,called premature ventricular contraction -induced cardiomyopathy.At present,it is necessary to further research the pathogenesis of premature ventricular contraction -induced cardiomyopathy and the risk factors for its development.Antiarrhythmic therapy or catheter ablation can prevent or even reverse premature ventricular contraction -induced cardiomyopathy,and catheter ablation is being evaluated as a first line therapy

参考文献/References:


[1]Duffee DF,Shen WK.Suppression of frequent premature ventricular contractions and improvement of left ventricular function in patients with presumed idiopathic dilated cardiomyopathy[J].Mayo Clin Proc,1998,73(5):430-433.

[2] Niwano S,Wakisaka Y,Niwano H,et al.Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular function[J].Heart,2009,95(15):1230-1237.

[3] 惠玲玲,张晓锋.室性早搏性心肌病[J].心脏杂志,2013,25(1):104-105+109.

[4] 郭继鸿.室早性心肌病发生机制的探讨[J].临床心电学杂志,2015,24(3):215-226.

[5] Akoum NW,Daccarett M,Wasmund SL,et al.An animal model for ectopy-induced cardiomyopathy[J].Pacing Clin Electrophysiol,2011,34(3):291-295.

[6] Wang Y,Eltit JM,Kaszala K,et al.Cellular mechanism of premature ventricular contraction-induced cardiomyopathy[J].Heart Rhythm,2014,11(11):2064-2072.

[7] Walters TE,Rahmutula D,Szilagyi J,et al.Left ventricular dyssynchrony predicts the cardiomyopathy associated with premature ventricular contractions[J].J Am Coll Cardiol 2018,72(23):2870-2882.

[8] 戈甜甜,鲁大胜,单其俊.室性早搏诱发心肌病的诊疗进展[J].中国心脏起搏与心电生理杂志,2017,31(4):294-297.

[9] del Carpio Munoz F,Syed FF,Noheria A,et al.Characteristics of premature ventricular complexes as correlates of reduced left ventricular systolic function: study of the burden,duration,coupling interval,morphology and site of origin of PVCs[J].J Cardiovasc Electrophysiol,2011,22(7):791-798.

[10] Yokokawa M,Kim HM,Good E,et al.Relation of symptoms and symptom duration to premature ventricular complex-induced cardiomyopathy[J].Heart Rhythm,2012,9(1):92-95.

[11] Baman TS,Lange DC,Ilg KJ,et al.Relationship between burden of premature ventricular complexes and left ventricular function[J].Heart Rhythm,2010,7(70):865-869.

[12] Tan AY,Hu YL,Potfay J,et al.Impact of ventricular ectopic burden in a premature ventricular contraction-induced cardiomyopathy animal model[J].Heart Rhythm,2016,13(3):755-761.

[13] Amir M,Mappangara I,Setiadji R,et al.Characteristics and prevalence of premature ventricular complex:a telemedicine study[J].Cardiol Res ,2019,10(5):285-292.

[14] Tran CT,Calkins H.Premature ventricular contraction-induced cardiomyopathy: an emerging entity[J].Expert Rev Cardiovasc Ther,2016,14(11):1227-1234.

[15] Dabbagh GS,Bogun F.Predictors and therapy of cardiomyopathy caused by frequent ventricular ectopy[J].Curr Cardiol Rep,2017,19(9):80.

[16] 何丽,苏立,殷跃辉.室性期前收缩对左心室结构与功能的影响[J].心血管病学进展,2018,39(6):907-910.

[17] Lee A,Denman R,Haqqani HM.Ventricular ectopy in the context of left ventricular systolic dysfunction: risk factors and outcomes following catheter ablation[J].Heart Lung Circ,2019,28(3):379-388.

[18] Panizo JG,Barra S,Mellor G,et al.Premature ventricular complex-induced cardiomyopathy[J].Arrhythm Electrophysiol Rev,2018,7(2):128-134.

[19] Latchamsetty R ,Bogun F.Premature ventricular complex-induced cardiomyopathy[J].JACC Clin Electrophysiol,2019,5(5):537-550.

[20] Krittayaphong R,Bhuripanyo K,Punlee K,et al.Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study[J].Am Heart J,2002,144(6):e10.

[21] Priori SG,Blomstr?m-Lundqvist C.2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs[J].Eur Heart J,2015,36(41):2757-2759.

[22] 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association task force on clinical practice Guidelines and the heart rhythm society[J].Circulation,2018,138(13):e419-e420.

[23] Latchamsetty R,Yokokawa M,Morady F,et al.Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes[J].JACC Clin Electrophysiol,2015,1(3):116-123.

[24] Penela D,Martínez M,Fernández-Armenta J,et al.Influence of myocardial scar on the response to frequent premature ventricular complex ablation[J].Heart,2019,105(5):378-383.

[25] 李赐恩,宋卫锋,王徐乐等.导管消融术后早期左室射血分数恢复对室性期前收缩心肌病远期预后的预测价值[J].临床心血管病杂志,2017,33(8):782-785.

相似文献/References:

[1]徐莉,黄晶.无症状性室性期前收缩预后和治疗进展[J].心血管病学进展,2015,(6):704.[doi:10.3969/j.issn.1004-3934.2015.06.012]
 XU Li,HUANG Jing.Advances in Prognosis and Management of Asymptomatic Premature Ventricular Complexes[J].Advances in Cardiovascular Diseases,2015,(6):704.[doi:10.3969/j.issn.1004-3934.2015.06.012]
[2]刘玉辉 王盼盼 陈椿.心房颤动性心肌病临床研究进展[J].心血管病学进展,2020,(12):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
 LIU Yuhui,WANG Panpan,CHEN Chun.Atrial Fibrillation-induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(6):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
[3]王前程 刘伟涛 周忠江.提高对甲状腺素转运蛋白淀粉样变性心肌病诊治的认识[J].心血管病学进展,2021,(3):228.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.009]
 WANG Qiancheng,LIU Weitao,ZHOU Zhongjiang.To Improve the Recognition of Diagnosis and Treatment of Transthyretin Amyloid Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(6):228.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.009]
[4]杭成文 崔鸣.Myomesin基因家族及其相关疾病的研究进展[J].心血管病学进展,2021,(4):314.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.007]
 HANG Chengwen,CUI Ming.Myomesin Gene Family and Related Diseases[J].Advances in Cardiovascular Diseases,2021,(6):314.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.007]
[5]徐尧 蔡衡 李洪仕.心房颤动合并心力衰竭的导管消融治疗[J].心血管病学进展,2021,(4):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
 XU Yao,CAI Heng,LI Hongshi.Role of Radiofrequency Ablation in Patients with Atrial Fibrillation and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(6):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
[6]刘珊珊,王岳恒,赵卉霖.肥厚心肌病动态梗阻的研究进展[J].心血管病学进展,2021,(6):508.[doi:10.16806/j.cnki.issn.1004-3934.20.06.008]
 LIU Shanshan,WANG Yueheng,ZHAO Huilin.Dynamic Obstruction in Hypertrophic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(6):508.[doi:10.16806/j.cnki.issn.1004-3934.20.06.008]
[7]周小龙 赵晓莹 赵新湘.射血分数正常的肥厚型心肌病患者心肌T1值和T2值研究[J].心血管病学进展,2021,(9):845.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
 ZHOU XiaolongZHAO Xiaoying,ZHAO Xinxiang.Study of T1 and T2 Values in Myocardium of Hypertrophic Cardiomyopathy with Normal Ejection Fraction[J].Advances in Cardiovascular Diseases,2021,(6):845.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[8]时向民 李健 李世兴 张闯.调节束起源室性心律失常的研究进展[J].心血管病学进展,2022,(9):769.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.001]
 SHI Xiangmin,L I Jian,L I Shixing,et al.Ventricular Arrhythmia Originated from Moderator Band[J].Advances in Cardiovascular Diseases,2022,(6):769.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.001]
[9]王帅兵 刘江文 黄从新.神经氨酸酶1在心血管疾病中的研究进展[J].心血管病学进展,2023,(11):982.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.006]
 WANG Shuaibing,LIU Jiangwen,HUANG Congxin.NEU1 in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2023,(6):982.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.006]
[10]黄勇淇 田龙海 杨龙.室性期前收缩心肌病[J].心血管病学进展,2022,(4):348.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.015]
 HUANG Yongqi,TIAN Longhai,YANG Long.Premature Ventricular Complexes Induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2022,(6):348.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.015]

更新日期/Last Update: 2020-09-21